Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 14, 2017
FRANKLIN LAKES, N.J., August 14, 2017 – BD (Becton, Dickinson and Company), a leading global medical technology company, has obtained 510(k) clearance from the U.S. Food and Drug Administration...
-
Aug 3, 2017
Click on the links below to view results for 2017 Third Fiscal Quarter: View Document Online PDF File of BD 2017 Third Fiscal Quarter Results About BD BD is one of the largest global medical...
-
Jul 19, 2017BD FACSLyric(TM) Flow Cytometer System with BD Multitest(TM) Assays Offers Reliability and Consistency
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)...
-
Jul 18, 2017New BD Kiestra(TM) Urine Culture App1 Drives Increased Lab Efficiency and Impacts Patient Management
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new technology that can automatically report and release negative urine cultures. Every...
-
Jun 20, 2017New Micro-Laparoscopic Instruments Offer Surgeons Less Invasive Option for Patients
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its new line of Snowden-Pencer((TM)) 3.0mm laparoscopic ergonomic take-apart...
-
Jun 13, 2017Leaders in flow cytometry tools collaborate to deliver cloud data management capabilities and streamline experimental execution
ASHLAND, Ore and FRANKLIN LAKES, N.J., June 13, 2017 ─ FlowJo, LLC, a life science informatics and data analysis company with 20 years of experience in software for analyzing single-cell data,...
-
Jun 6, 2017
FRANKLIN LAKES, N.J., June 6, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2016 Sustainability Report. BD’s...
-
Jun 5, 2017Extends BD MAX(TM) Enteric Panel Portfolio with latest Molecular Test that Targets Infectious Diarrhea
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its newly developed molecular test for detecting harmful intestinal bacteria...
-
May 15, 2017
Franklin Lakes, NJ (May 15, 2017) - BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming...
-
May 9, 2017BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room SettingNew Collaboration Aims to Provide Greater Visibility into Surgical Tracking and Loaner Tray Management
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and UniteOR, Inc., announced today the integration between BD's IMPRESS(TM) instrument management system...
